Olivia S Chu, MD | UniHealth

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chu’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A16017 · Cancelled

Licence status: Cancelled · since 1954 · University of California San Francisco School of Medicine.

License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$9,717

Medicare paid this office $9,717 for 99 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Telephone medical discussion with physician, 11-20 minutes	39	$3,026	$70
Return visit (30+ min)	25	$2,797	$100
Telephone medical discussion with physician, 21-30 minutes	21	$2,055	$89

Who their Medicare patients are

99 Original Medicare patients in 2024. Average age 69 · Women 43% · Also on Medicaid 34% · Health risk score 1.50. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 66% · Diabetes 31% · Depression 23% · Coronary heart disease 22% · Chronic kidney disease 17% · Heart failure 16% · Atrial fibrillation 14% · Stroke 14% · COPD 13% · Cancer 12%.

The office billed $50,121, Medicare allowed $13,211 and paid $9,717; for 126 services of 8 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	99	126	69	1.50	$50,121	$9,717
2023	53	70	68	1.27	$15,803	$3,421
2022	34	45	71	1.31	$9,303	$2,234
2021	18	23	70	1.08	$10,331	$1,194
2014	13	14	68	1.36	$2,344	$749

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Sort by

Original Medicare services billed in 2023

Telephone medical discussion with physician, 21-30 minutes	15	$1,334	$74
Telephone medical discussion with physician, 11-20 minutes	23	$1,244	$46

2022: 2 services

Sort by

Original Medicare services billed in 2022

Telephone medical discussion with physician, 11-20 minutes	15	$832	$49
Telephone medical discussion with physician, 5-10 minutes	14	$417	$28

Drugs they prescribed that Part D paid

$710,944

Pharmacies billed $710,944 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

725 generic and fewer than 11 brand-name prescriptions · $710,944 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Genotropin	93	$266,448	$2,865
Norditropin Flexpro	22	$46,090	$2,095
Humatrope	22	$22,777	$1,035
Testosterone	93	$22,586	$243
Hydrocortisone	212	$15,550	$73

See all 15 drugs

Sort by

Every Part D drug this clinician prescribed

Genotropin	93	$266,448	$2,865
Norditropin Flexpro	22	$46,090	$2,095
Humatrope	22	$22,777	$1,035
Testosterone	93	$22,586	$243
Hydrocortisone	212	$15,550	$73
Desmopressin Acetate	66	$14,072	$213
Omnitrope	17	$10,483	$617
Bromocriptine Mesylate	14	$4,406	$315
Octreotide Acetate	11	$3,493	$318
Levothyroxine	276	$3,380	$12
Cabergoline	36	$2,337	$65
Testosterone Cypionate	35	$2,050	$59
Synthroid	20	$1,479	$74
Liothyronine	17	$834	$49
Prednisone	52	$684	$13

Year by year

Sort by

Part D prescribing by year

2024	1,080	157	None	None	$710,944
2023	1,052	124	None	None	$737,589
2022	883	116	None	None	$616,273
2021	918	113	None	None	$552,929
2020	728	105	None	50%	$551,118
2019	664	103	None	58%	$412,892
2018	684	97	None	50%	$274,788
2017	592	90	None	52%	$262,651
2016	601	82	0% (0)	None	$198,708
2015	624	87	0% (0)	53%	$233,137
2014	555	68	None	None	$183,875
2013	346	57	None	44%	$125,759

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 15 drugs

Sort by

Part D drugs prescribed in 2023

Somavert	11	$261,348	$23,759
Genotropin	109	$209,457	$1,922
Testosterone	83	$38,644	$466
Humatrope	20	$26,863	$1,343
Hydrocortisone	211	$18,959	$90
Desmopressin Acetate	62	$17,008	$274
Omnitrope	19	$15,861	$835
Octreotide Acetate	13	$10,188	$784
Bromocriptine Mesylate	14	$6,435	$460
Levothyroxine	271	$5,565	$21
Cabergoline	36	$2,661	$74
Testosterone Cypionate	31	$1,686	$54
Prednisone	78	$1,179	$15
Synthroid	12	$1,155	$96
Liothyronine	11	$649	$59

2022: 13 drugs

Sort by

Part D drugs prescribed in 2022

Genotropin	114	$196,942	$1,728
Norditropin Flexpro	15	$78,275	$5,218
Humatrope	19	$21,053	$1,108
Testosterone	61	$18,974	$311
Desmopressin Acetate	50	$17,230	$345
Omnitrope	20	$13,380	$669
Hydrocortisone	176	$13,351	$76
Bromocriptine Mesylate	13	$7,527	$579
Levothyroxine	210	$4,055	$19
Cabergoline	39	$2,287	$59
Testosterone Cypionate	22	$1,548	$70
Synthroid	15	$1,430	$95
Prednisone	55	$851	$15

2021: 13 drugs

Sort by

Part D drugs prescribed in 2021

Genotropin	87	$140,489	$1,615
Humatrope	28	$37,575	$1,342
Testosterone	56	$17,917	$320
Desmopressin Acetate	64	$15,556	$243
Hydrocortisone	190	$14,643	$77
Omnitrope	17	$11,210	$659
Bromocriptine Mesylate	17	$8,356	$492
Octreotide Acetate	13	$6,595	$507
Levothyroxine	213	$5,428	$25
Cabergoline	38	$2,453	$65
Synthroid	21	$2,082	$99
Testosterone Cypionate	26	$1,480	$57
Prednisone	52	$976	$19

2020: 14 drugs

Sort by

Part D drugs prescribed in 2020

Somavert	11	$226,115	$20,556
Genotropin	45	$126,695	$2,815
Nutropin Aq Nuspin	17	$43,990	$2,588
Omnitrope	26	$39,283	$1,511
Testosterone	36	$17,780	$494
Desmopressin Acetate	59	$13,938	$236
Bromocriptine Mesylate	19	$9,593	$505
Hydrocortisone	151	$8,259	$55
Octreotide Acetate	13	$5,541	$426
Levothyroxine	174	$4,853	$28
Cabergoline	25	$2,102	$84
Synthroid	16	$1,827	$114
Prednisone	51	$984	$19
Testosterone Cypionate	17	$915	$54

2019: 12 drugs

Sort by

Part D drugs prescribed in 2019

Genotropin	41	$63,203	$1,542
Omnitrope	18	$41,485	$2,305
Nutropin Aq Nuspin	16	$35,777	$2,236
Testosterone	30	$28,529	$951
Desmopressin Acetate	59	$14,274	$242
Bromocriptine Mesylate	16	$9,699	$606
Hydrocortisone	168	$9,394	$56
Octreotide Acetate	11	$4,228	$384
Levothyroxine	157	$3,865	$25
Cabergoline	28	$2,407	$86
Testosterone Cypionate	14	$908	$65
Prednisone	28	$710	$25

2018: 15 drugs

Sort by

Part D drugs prescribed in 2018

Nutropin Aq Nuspin	25	$52,630	$2,105
Norditropin Flexpro	28	$48,967	$1,749
Humatrope	14	$32,746	$2,339
Androgel	21	$25,831	$1,230
Desmopressin Acetate	59	$14,441	$245
Testosterone	15	$11,512	$767
Androderm	11	$10,152	$923
Bromocriptine Mesylate	16	$7,820	$489
Hydrocortisone	135	$7,348	$54
Cabergoline	57	$6,239	$109
Octreotide Acetate	11	$4,783	$435
Levothyroxine	174	$4,564	$26
Testosterone Cypionate	34	$1,266	$37
Synthroid	17	$1,012	$60
Prednisone	16	$299	$19

2017: 13 drugs

Sort by

Part D drugs prescribed in 2017

Nutropin Aq Nuspin	38	$60,072	$1,581
Androgel	37	$49,710	$1,344
Humatrope	20	$31,293	$1,565
Norditropin Flexpro	26	$29,304	$1,127
Omnitrope	19	$23,887	$1,257
Desmopressin Acetate	43	$8,263	$192
Hydrocortisone	111	$8,209	$74
Cabergoline	49	$6,209	$127
Levothyroxine	107	$3,252	$30
Ketoconazole	13	$1,227	$94
Testosterone Cypionate	17	$749	$44
Synthroid	21	$661	$31
Prednisone	27	$570	$21

2016: 14 drugs

Sort by

Part D drugs prescribed in 2016

Androgel	40	$48,624	$1,216
Humatrope	26	$32,925	$1,266
Norditropin Flexpro	31	$25,209	$813
Nutropin Aq Nuspin	14	$16,351	$1,168
Axiron	13	$13,116	$1,009
Omnitrope	26	$13,003	$500
Desmopressin Acetate	59	$7,310	$124
Bromocriptine Mesylate	12	$7,034	$586
Hydrocortisone	102	$6,195	$61
Cabergoline	31	$5,644	$182
Levothyroxine	136	$3,824	$28
Synthroid	19	$895	$47
Prednisone	33	$644	$20
Testosterone Cypionate	15	$431	$29

2015: 15 drugs

Sort by

Part D drugs prescribed in 2015

Somavert	11	$42,006	$3,819
Humatrope	17	$32,073	$1,887
Androgel	29	$27,334	$943
Nutropin Aq	18	$17,667	$982
Desmopressin Acetate	59	$14,713	$249
Axiron	14	$12,107	$865
Norditropin Flexpro	21	$10,178	$485
Omnitrope	22	$10,153	$461
Hydrocortisone	115	$7,728	$67
Cabergoline	25	$5,729	$229
Bromocriptine Mesylate	12	$5,250	$437
Levothyroxine	137	$3,436	$25
Pataday	16	$2,536	$158
Synthroid	14	$825	$59
Prednisone	27	$569	$21

2014: 13 drugs

Sort by

Part D drugs prescribed in 2014

Somavert	12	$35,632	$2,969
Androgel	56	$33,267	$594
Desmopressin Acetate	65	$18,335	$282
Nutropin Aq	13	$11,831	$910
Norditropin Flexpro	22	$9,915	$451
Omnitrope	19	$7,763	$409
Cabergoline	28	$5,297	$189
Hydrocortisone	81	$5,129	$63
Levothyroxine	129	$3,365	$26
Bromocriptine Mesylate	13	$3,304	$254
Actonel	11	$2,622	$238
Synthroid	22	$1,431	$65
Prednisone	38	$896	$24

2013: 10 drugs

Sort by

Part D drugs prescribed in 2013

Somavert	16	$25,400	$1,587
Androgel	23	$16,522	$718
Desmopressin Acetate	39	$11,242	$288
Nutropin Aq	12	$10,099	$842
Norditropin Flexpro	11	$4,630	$421
Hydrocortisone	47	$3,742	$80
Cabergoline	15	$2,314	$154
Levothyroxine	95	$1,608	$17
Synthroid	11	$493	$45
Prednisone	23	$220	$10

Money from drug and device companies

$50 in 2021

A payment is not proof that care is biased.

Sort by

Payments by company

Biohaven Pharmaceuticals	Nurtec Odt	$50	1 payment Meals for Nurtec Odt · 2021-03-25 · $50

See the published payment

Sort by

Every published payment

Biohaven Pharmaceuticals	Meals · 2021-03-25	Nurtec Odt	$50

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1851617609
Licence: CA 16017California A16017: Cancelled
Trained: Johns Hopkins University School of Medicine, 2005 · 21 years ago
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2010-04-19
NPI last updated: 2025-12-30
NPI record certified: 2025-12-30

This is when the NPI record was last certified, not a medical board exam.